Final screening round of the NELSON lung cancer screening trial: The effect of a 2.5-year screening interval

Thorax

Volumn 72, Issue 1, 2017, Pages 48-56

  Yousaf Khan, Uraujh ^a   Van Der Aalst, Carlijn ^a   De Jong, Pim A ^b   Heuvelmans, Marjolein ^c   Scholten, Ernst ^b,d   Lammers, Jan Willem ^b   Van Ooijen, Peter ^c   Nackaerts, Kristiaan ^e   Weenink, Carla ^d   Groen, Harry ^c   Vliegenthart, Rozemarijn ^c   Ten Haaf, Kevin ^a   Oudkerk, Matthijs ^c   De Koning, Harry ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d Department of Orthopaedic Surgery   (Netherlands)

^e UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Clinical Epidemiology; Lung Cancer; Non Small Cell Lung Cancer; Small Cell Lung Cancer; Tobacco and the lung

Indexed keywords

ADULT; ARTICLE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LUNG ALVEOLUS CELL CARCINOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NON SMALL CELL LUNG CANCER; RANDOMIZED CONTROLLED TRIAL; SMALL CELL LUNG CANCER; SQUAMOUS CELL LUNG CARCINOMA; SURVIVAL TIME; THORAX RADIOGRAPHY; X-RAY COMPUTED TOMOGRAPHY; AGED; DIAGNOSTIC IMAGING; EARLY CANCER DIAGNOSIS; LUNG TUMOR; MIDDLE AGED; PATHOLOGY; PROCEDURES; SECONDARY; SQUAMOUS CELL CARCINOMA; TIME FACTOR;

AGED; CARCINOMA, SQUAMOUS CELL; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; SMALL CELL LUNG CARCINOMA; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84977501755     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2016-208655     Document Type: Article

References (22)

1. Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014. CA Cancer J Clin 2014;64:9-29.
2. Aberle DR, Berg CD, Black WC, et al., National Lung Screening Trial Research Team. The National Lung Screening Trial: overview and study design. Radiology 2011;258:243-53.
3. Aberle DR, Adams AM, Berg CD, et al., National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395-409.
4. Moyer VA, U.S. Preventive Services Task Force. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2014;160:330-8.
5. de Koning H, Meza R, Plevritis S, et al. Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force. Ann Intern Med 2014;160:311-20.
6. Pastorino U, Rossi M, Rosato V, et al. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev 2012;21:308-15.
7. Sverzellati N, Silva M, Calareso G, et al. Low-dose computed tomography for lung cancer screening: comparison of performance between annual and biennial screen. Eur Radiol. Published Online First: 11 Feb 2016. doi:10.1007/s00330-016-4228-3
8. van Iersel CA, de Koning HJ, Draisma G, et al. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 2007;120:868-74.
9. van Klaveren RJ, Oudkerk M, Prokop M, et al. Management of lung nodules detected by volume CT scanning. N Engl J Med 2009;361:2221-9.
10. Xu DM, Gietema H, de Koning H, et al. Nodule management protocol of the NELSON randomised lung cancer screening trial. Lung Cancer 2006;54:177-84.
11. Horeweg N, van der Aalst CM, Thunnissen E, et al. Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial. Am J Respir Crit Care Med 2013;187:848-54.
12. Horeweg N, van der Aalst CM, Vliegenthart R, et al. Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trial. Eur Respir J 2013;42:1659-67.
13. Horeweg N, Nackaerts K, Oudkerk M, et al. Low-dose computed tomography screening for lung cancer: results of the first screening round. J Comp Eff Resp 2013;2:433-6.
14. Horeweg N, Scholten ET, de Jong PA, et al. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers. Lancet Oncol 2014;15:1342-50.
15. Xie X, Willemink MJ, Zhao Y, et al. Inter-and intrascanner variability of pulmonary nodule volumetry on low-dose 64-row CT: an anthropomorphic phantom study. Br J Radiol 2013;86:20130160.
16. Xie X, Zhao Y, Snijder RA, et al. Sensitivity and accuracy of volumetry of pulmonary nodules on low-dose 16-and 64-row multi-detector CT: an anthropomorphic phantom study. Eur Radiol 2013;23:139-47.
17. Wang Y, van Klaveren RJ, van der Zaag-Loonen HJ, et al. Effect of nodule characteristics on variability of semiautomated volume measurements in pulmonary nodules detected in a lung cancer screening program. Radiology 2008;248:625-31.
18. Ru Zhao Y, Xie X, de Koning H, et al. NELSON lung cancer screening study. Cancer Imaging 2011;11(Spec No A):S79-84.
19. van der Aalst C, van Klaveren R, de Koning HJ, et al. Does participation to screening unintentionally influence lifestyle behaviour and thus lifestyle-related morbidity? Best Pract Res Clin Gastroenterol 2010;24:465-78.
20. Saghir Z, Dirksen A, Ashraf H, et al. CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT. Thorax 2012;67:296-301.
21. Aberle DR, DeMello S, Berg CD, et al. Results of the two incidence screenings in The National Lung Screening Trial. N Engl J Med 2013;369:920-31.
22. Wille MM, Dirksen A, Ashraf H, et al. Results of the randomized Danish lung cancer screening trial with focus on high-risk profiling. Am J Respir Crit Care Med 2016;193:542-51.